| http://www.w3.org/ns/prov#value | - As genetic, proteomic, imaging, and other new technologies become more sophisticated and our knowledge of tumor biology and signaling pathways advances, so too does our ability to molecularly characterize individual tumors and identify germline determinants of patient prognosis and response, said David Sidransky, M.D., meeting chairperson and professor of Otolaryngology - Head and Neck Surgery,
|
